USE OF HYPERBARIC PRILOCAINE IN AMBULATORY SURGERY

USE OF HYPERBARIC PRILOCAINE IN AMBULATORY SURGERY F. Troisi, A. Ferrara, P. Merlin, F. Sacco, E. Finetti, S. Collini Anestesia e Ranimazione, Az Ospedaliera S Andrea, Roma, Italy Background and aims: Data on prilocaine use for ambulatory intrathecal anaesthesia are limited. In this randomized study we compared 2% hyperbaric prilocaine and sufentanil with 2% hyperbaric bupivacaine and sufentanil for spinal anesthesia in outpatients undergoing elective anorectal surgery without increasing side - effects or delaying. Methods: Patients ASA I-III were randomly allocated to receive 30mg hyperbaric prilocaine plus 5 microg sufentanyl (group PS,n=20) or 10 mg hyperbaric bupivacaine plus 5 microg sufentanyl (group BS, n=20) in sitting position. After sitting for 3 min (group PS) and 10 min (group BS), patients were positioned for surgery. Written informed consent was obtained from all subjects. Results: There were no significant differences in intraoperative outcomes (hypotension, bradycardia, respirator depression) but mean recovery, discharge time, postoperative pain and urinary retention were significantly shorter in group PS. Conclusions: This study demonstrates the superiority of the combination of low-dose hyperbaric prilocaine and sufenatnyl for spinal anaesthesia in ambulatory anorectal surgery. It is an excellent alternative to bupivacain because of faster attainment and resolution block, greater haemodynamic stability, earlier deambulation, reduced risk of urinary retention and early patients discharge. Assigned speakers: Dr. Fabiana Troisi, Az Ospedaliera S Andrea , Roma , Italy Assigned in sessions: 06.09.2012, 08:00-18:30, Posters for Electronic Viewing, Posters for Electronic Viewing, Poster Area 07.09.2012, 08:00-18:30, Posters for Electronic Viewing, Posters for Electronic Viewing, Poster Area